Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Chen

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Frontiers in Medicine|November 17, 2022
Sentiment analysis of tweets on alopecia areata, hidradenitis suppurativa, and psoriasis: Revealing the patient experienceIrene Tai-Lin Lee, Sin-Ei Juang, Steven T Chen, et al.
Journal of the American Academy of Dermatology|February 8, 2026
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Psoriasis and Comorbid Type 2 Diabetes: A Population-based Target Trial EmulationDebby Cheng, Helen Ji, Nicholas Theodosakis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2026
Effect of GLP-1RA on mortality and cardiovascular risk in adults with psoriasis and type 2 diabetesClaire Lin, Natalie Braun, Sydney Corey, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 20, 2025
Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-AnalysisKevin Sheng-Kai Ma, Chin-Hsuan Shen, Meng-Han Chiang, et al.
Journal of the American Academy of Dermatology|April 20, 2021
Response to: "Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions"Gabriel E Molina, Tracey S Otto, Zizi Yu, et al.
Journal of the American Academy of Dermatology|March 2, 2025
Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: A multicenter retrospective cohort studyBaraa A Hijaz, Natalie Braun, Kerry L Reynolds, et al.
Journal of the American Academy of Dermatology|June 13, 2025
Severity and Progression of Dermatologic Adverse Events Associated with Tebentafusp: A Retrospective Multicenter Cohort StudyGrant J Riew, Baraa A Hijaz, Rizwan Haq, et al.
Journal of the American Academy of Dermatology|September 20, 2023
Prevalence of autoimmune diseases in cutaneous B-cell lymphoma: A retrospective cross sectional analysisDavid Xiang, Katherine Perlman, Bethany Brumbaugh, et al.
Pediatric Dermatology|December 18, 2020
Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009-2015Erin K Collier, Jason J Yang, Sophia Sangar, et al.
Journal of the American Academy of Dermatology|September 13, 2025
Risk of cutaneous T-cell lymphoma in patients with autoimmune diseasesBethany Brumbaugh, Mike Westmeijer, Beatrix Thompson, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Frontiers in Medicine|November 17, 2022
Sentiment analysis of tweets on alopecia areata, hidradenitis suppurativa, and psoriasis: Revealing the patient experienceIrene Tai-Lin Lee, Sin-Ei Juang, Steven T Chen, et al.
Journal of the American Academy of Dermatology|February 8, 2026
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Psoriasis and Comorbid Type 2 Diabetes: A Population-based Target Trial EmulationDebby Cheng, Helen Ji, Nicholas Theodosakis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2026
Effect of GLP-1RA on mortality and cardiovascular risk in adults with psoriasis and type 2 diabetesClaire Lin, Natalie Braun, Sydney Corey, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 20, 2025
Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-AnalysisKevin Sheng-Kai Ma, Chin-Hsuan Shen, Meng-Han Chiang, et al.
Journal of the American Academy of Dermatology|April 20, 2021
Response to: "Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions"Gabriel E Molina, Tracey S Otto, Zizi Yu, et al.
Journal of the American Academy of Dermatology|March 2, 2025
Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: A multicenter retrospective cohort studyBaraa A Hijaz, Natalie Braun, Kerry L Reynolds, et al.
Journal of the American Academy of Dermatology|June 13, 2025
Severity and Progression of Dermatologic Adverse Events Associated with Tebentafusp: A Retrospective Multicenter Cohort StudyGrant J Riew, Baraa A Hijaz, Rizwan Haq, et al.
Journal of the American Academy of Dermatology|September 20, 2023
Prevalence of autoimmune diseases in cutaneous B-cell lymphoma: A retrospective cross sectional analysisDavid Xiang, Katherine Perlman, Bethany Brumbaugh, et al.
Pediatric Dermatology|December 18, 2020
Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009-2015Erin K Collier, Jason J Yang, Sophia Sangar, et al.
Journal of the American Academy of Dermatology|September 13, 2025
Risk of cutaneous T-cell lymphoma in patients with autoimmune diseasesBethany Brumbaugh, Mike Westmeijer, Beatrix Thompson, et al.
Pageof 16